Cano Megías Marta, Guisado Vasco Pablo, González Albarrán Olga, Lamas Ferreiro Adelaida, Máiz Carro Luis
Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España.
Servicio de Medicina Interna, Hospital Quirón San Camilo, Madrid, España.
Endocrinol Nutr. 2015 Nov;62(9):422-9. doi: 10.1016/j.endonu.2015.06.009. Epub 2015 Aug 24.
Nutritional status is a prognostic factor in cystic fibrosis. Prevention of nutritional impairment and weigh loss are major clinical objectives because they are associated with worsening of lung function and increased mortality.
To identify a potential relationship of clinical nutrition parameters, and their relative changes, with lung function (FEV1%) in a cohort of adolescent and adult patients with CF.
A retrospective analysis of 64 patients older than 14years. Weight, height, BMI, and lung function data were collected at a period of disease stability, both in the year of the first abnormal oral glucose tolerance test (OGTT) and in the previous year. Relative changes in weight and BMI, and their relationship with FEV1%, were determined by linear regression and ANOVA tests; influence of gender and diabetes was also assessed.
Mean age of the series (28 females and 36 males) was 26.8years. Normal glucose tolerance (NGT) was found in 26.7%, while 18.3% had diabetes without impaired fasting glucose (CFRD without FPG). Mean BMI was 20.32, with a mean weight of 53.53kg; 32.8% had BMI<18.5, and only 4.7% were overweight. Overall, a positive relative change in weight (≥6%) was associated with an increase in FEV1% (9.31%), as compared to those with a greater weight loss (at least 2%), who had a 12.09% fall in FEV1. Patients with CFRD without FPG had poorer lung function if they had a negative relative change in weight by at least 2% as compared to NGT.
In patients with CF, a relative weight gain is positively associated to FEV1%, while a relative weight loss of at least 2% has a significant negative impact on lung function.
营养状况是囊性纤维化的一个预后因素。预防营养损害和体重减轻是主要的临床目标,因为它们与肺功能恶化和死亡率增加有关。
在一组青少年和成年囊性纤维化患者中,确定临床营养参数及其相对变化与肺功能(第一秒用力呼气容积百分比,FEV1%)之间的潜在关系。
对64名年龄超过14岁的患者进行回顾性分析。在疾病稳定期,收集首次口服葡萄糖耐量试验(OGTT)异常当年及前一年的体重、身高、体重指数(BMI)和肺功能数据。通过线性回归和方差分析确定体重和BMI的相对变化及其与FEV1%的关系;还评估了性别和糖尿病的影响。
该系列患者(28名女性和36名男性)的平均年龄为26.8岁。26.7%的患者葡萄糖耐量正常(NGT),而18.3%的患者患有非空腹血糖未受损的糖尿病(无空腹血糖受损的囊性纤维化相关糖尿病,CFRD without FPG)。平均BMI为20.32,平均体重为53.53kg;32.8%的患者BMI<18.5,只有4.7%的患者超重。总体而言,与体重下降较大(至少2%)的患者相比,体重相对增加(≥6%)与FEV1%增加(9.31%)相关,体重下降较大的患者FEV1下降了12.09%。与NGT患者相比,无空腹血糖受损的CFRD患者如果体重相对下降至少2%,其肺功能较差。
在囊性纤维化患者中,体重相对增加与FEV1%呈正相关,而体重相对下降至少2%对肺功能有显著负面影响。